| CAT No: | CL-IZU-002 |
| CAS No: | NA |
| Mol.F: | C12H11BrN8O2 |
| Mol.Wt.: | 379.2 |
| Chemical Name: | N-(1-(8-Bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)azetidin-3-yl)-N-methylnitramide |
| Inventory Status: | Custom synthesis |
This impurity is related to Izuforant Impurity 1 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Izuforant Impurity 1 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-(1-(8-Bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)azetidin-3-yl)-N-methylnitramideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Izuforant Molecular Formula: C12H11BrN8O2
Molecular Weight: 379.2
Storage: Store in a cool, dry place.
| Product Name: | Izuforant Impurity 1 |
| CAS No: | |
| Mol.F.: | C12H11BrN8O2 |
| Mol.Wt.: | 379.2 |
Cat. No: CL-IZU-NO-01
CAS No: NA
Mol. F: C12H11BRN8O
Mol. Wt: 363.2
Inv. Status: Custom Synthesis
Cat. No: CL-IZU-001
CAS No: 1429374-83-3
Mol. F: C12H12BrN7
Mol. Wt: 334.2
Inv. Status: Custom Synthesis
Cat. No: CL-IZU-003
CAS No: NA
Mol. F: C9H17N3O4
Mol. Wt: 231.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: